Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-03

Clinical Trial Update: EntrestoTM (LCZ696) In Advanced Heart Failure (LIFE Study) [Phase 4]

View source ↗

Summary

Phase 4 LIFE study update for Entresto (LCZ696) in advanced heart failure; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Entresto (sacubitril/valsartan)

Snippet

Sponsor: Duke University | Conditions: Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2021-12-03